JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 49(2015) N 2 p. 179-184; DOI 10.1134/S0026893315010197 Full Text

D.V. Yudkin1,2*, N.A. Lemskaya1, I.V. Grischenko2, A.A. Dolskiy2

Chromatin changes caused by expansion of CGG repeats in fmr1 gene

1Institute of Molecular and Cellular Biology, Siberian Branch, Russian Academy of Science, Novosibirsk, 630090 Russia
2Novosibirsk State University, Novosibirsk, 630090 Russia

*dim@mcb.nsc.ru
Received - 2014-07-14; Accepted - 2014-08-12

Fragile X syndrome is an inherited neurodegenerative disease with a frequency of 1/4000 -1/6000. It is the main cause of inheritable mental retardation. The progression of the disorder is caused by CGG repeat expansion in 5' UTR of fmr1 (fragile X mental retardation 1) gene. The normal allele contains 54 repeats. Alleles containing 55-200 repeats induce fragile X-associated disorders: fragile X-associated tremor/ataxia syndrome and fragile-X associated primary ovarian insufficiency. Alleles containing 200 repeats induce fragile X syndrome. The absence of FMRP protein is the main reason for the progression of the syndrome. FMRP is RNA-binding protein responsible for neuronal differentiation. In case of increasing CGG triplets number the expression of fmr1 gene is repressed. Results of CGG expansion are DNA methylation, histone methylation and deacetylation. Repression transcription factors bind this chromatin and lead to the progression of the disorder. In this review, we discuss how heterochromatinization is induced by CGG repeat expansion in the promoter region of fmr1 gene.

fragile X syndrome, heterochromatinization, transcription, expression, methylation, acetylation, histones, tremor/ataxia syndrome, primary ovarian insufficiency



JMB-FOOTER RAS-JOURNALS